About BioImagene
BioImagene is a company based in Sunnyvale (United States) founded in 2003 was acquired by Roche in August 2010.. BioImagene has raised $40.2 million across 5 funding rounds from investors including Roche, Burrill and Company and Next47. The company has 40 employees as of December 31, 2009. BioImagene has completed 1 acquisition, including Tissue Informatic. BioImagene operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Sunnyvale, United States
- Employees 40 as on 31 Dec, 2009
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioimagene Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
62 people
Software Development Team
54 people
Human Resources and Administration
40 people
Finance and Accounting
37 people
Operations Team
36 people
Product Management Team
31 people
Sales and Marketing
22 people
Senior Team
19 people
Unlock access to complete
Funding Insights of BioImagene
BioImagene has successfully raised a total of $40.2M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(01 Jun 2003)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2008 | Amount | Series D - BioImagene | Valuation |
investors |
|
| Apr, 2008 | Amount | Series D - BioImagene | Valuation |
investors |
|
| Oct, 2004 | Amount | Series B - BioImagene | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioImagene
BioImagene has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche, Burrill and Company and Next47. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture investments in systems, infrastructure, and applications for enterprise founders.
|
Founded Year | Domain | Location | |
|
Strategic investments in healthcare technologies and data innovations.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in technology and healthcare sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioImagene
BioImagene has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Tissue Informatic. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Tissue imaging systems are developed for biotechnology quantitative analysis.
|
1998 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - BioImagene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioimagene Comparisons
Competitors of BioImagene
BioImagene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BioImagene
When was BioImagene founded?
BioImagene was founded in 2003.
Where is BioImagene located?
BioImagene is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is BioImagene a funded company?
BioImagene is a funded company, having raised a total of $40.2M across 5 funding rounds to date. The company's 1st funding round was a Series B of $4.2M, raised on Jun 01, 2003.
How many employees does BioImagene have?
As of Dec 31, 2009, the latest employee count at BioImagene is 40.
What does BioImagene do?
BioImagene was founded in 2003 and is based in Sunnyvale, United States, within the digital pathology sector. IHC algorithms are provided for cancers including breast (HER2, ERPR, p53, Ki67), brain and prostate (Ki67), multiple myeloma (CD138), and lymphoma (CD3CD20). The iSlide input device is offered for microscope-based manipulation of digital slide images, while iScan Coreo Au scanners support applications such as image analysis, telepathology, remote microscopy, and education.
Who are the top competitors of BioImagene?
BioImagene's top competitors include Guardant Health, Foundation Medicine and Natera.
How many acquisitions has BioImagene made?
BioImagene has made 1 acquisition, including Tissue Informatic.
Who are BioImagene's investors?
BioImagene has 10 investors. Key investors include Roche, Burrill and Company, Next47, Ascension Ventures, and National Healthcare Services.